LyondellBasell Industries N.V. - Q3 2025 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2025. LyondellBasell Industries N.V. is a global manufacturer of chemicals and polymers. In February 2025, the company ceased operations at its Houston refinery, reporting the refining business as a discontinued operation. The company operates through five reportable segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), and Technology.
Key Financial Metrics
| Metric (Millions USD) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Revenues | $7,727 | $8,604 | $23,062 | $25,586 |
| Operating (Loss) Income | $(731) | $865 | $(332) | $2,515 |
| Net (Loss) Income | $(890) | $573 | $(598) | $1,970 |
| Net (Loss) Income Attributable to Shareholders | $(892) | $571 | $(603) | $1,965 |
| Diluted EPS (Continuing Ops) | $(2.58) | $1.91 | $(2.05) | $6.11 |
| EBITDA (Total) | $(397) | $1,234 | $715 | $3,877 |
| Cash from Operating Activities (9M) | $755 | $1,904 | - | - |
| Cash and Cash Equivalents (End of Period) | $1,784 | - | - | - |
| Total Debt (Current + Long-term) | $11,719 | - | - | - |
Note: Q3 2025 results include significant non-cash impairment charges. Cash flow figures provided are for the nine-month period ended September 30, 2025.
Material Changes vs. Prior Period
- Impairment Charges: The primary driver of the Q3 2025 loss was non-cash impairment charges totaling $1,202 million ($972 million goodwill, $230 million other). These were concentrated in the O&P-EAI and APS segments due to a prolonged downturn in the European petrochemical and global automotive industries and a decline in market capitalization.
- Revenue Decline: Revenues decreased 10% year-over-year for the nine months ended September 30, 2025, driven by lower average sales prices (7% impact) and lower sales volumes (4% impact) due to weak demand.
- Discontinued Operations: The refining business is now reported as discontinued. The nine-month 2025 period included a $196 million LIFO benefit from inventory liquidation related to the refinery exit.
- Segment Performance:
- O&P-Americas: EBITDA improved sequentially in Q3 due to higher olefins margins but declined year-over-year due to higher feedstock costs.
- O&P-EAI: EBITDA turned negative in Q3 ($-381 million) primarily due to a $400 million goodwill impairment.
- APS: EBITDA turned negative in Q3 ($-746 million) primarily due to a $782 million impairment charge related to the automotive sector downturn.
Guidance, Outlook, and Risks
- Asset Sale: In October 2025, the company entered a sales agreement for select European olefins and polyolefins assets (Berre, Mönchsmünster, Carrington, Tarragona). Closing is expected in H1 2026. The company anticipates a loss on sale of $700 million to $900 million, including a $300 million cash contribution.
- Cash Improvement Plan: Announced in April 2025, targeting $600 million in annualized savings for 2025 via capital deferral, working capital reduction, and fixed cost cuts. As of Q3, $27 million in costs have been incurred.
- Capital Allocation: The company targets returning 70% of free cash flow to shareholders. However, the Senior Revolving Credit Facility was amended in September 2025 to restrict share repurchases (except to offset dilution) if the leverage ratio exceeds 4.00 to 1.00.
- Outlook: Q4 2025 is expected to be impacted by seasonality and lower operating rates. The company plans to idle a cracker in Wesseling, Germany, and a PO/SM unit in Channelview, Texas, in November 2025 for maintenance and demand alignment.
- Risks: Key risks include raw material price volatility, global oversupply, geopolitical instability, and the ability to maintain investment-grade credit ratings amidst the current downturn.
- Impairment Validity: Verify the assumptions used in the $1.2 billion impairment test (discount rates, cash flow projections) for O&P-EAI and APS segments.
- European Asset Sale: Monitor the progress of the European asset divestiture, specifically the $300 million cash contribution requirement and the expected $700-$900 million loss on closing.
- Liquidity Position: Assess the impact of the $1.6 billion decrease in cash and cash equivalents over the nine-month period against the $4.65 billion in unused credit facility availability.
- Debt Covenants: Confirm compliance with the amended leverage ratio covenants (up to 4.50:1 through mid-2027) and restrictions on dividends and buybacks.
- UK Tax Valuation Allowance: Review the rationale for the valuation allowance established against UK deferred tax assets, which impacted the effective tax rate.